Extractions: The How and Why

Operating room with monitor

Published:

May 29, 2020

BiocompCHATibility

A NAMSA podcast series that addresses specific medical device evaluation scenarios and challenges.

There are many mentions of extractions in medical device testing. In this episode, our hosts discuss ISO 10993-12 for sample preparations and extraction conditions. What happens to a sample when it’s received at a laboratory before they begin the testing? How do they actually get an extract out of a piece of plastic and when has the extraction gone too far? All of this and more are answered in this episode of BiocompCHATibility.

“If you are looking at the biocompatibility testing, the concept of extractions is going to come up eventually. Basically, trying to get something that we can dose into a study, whatever study that you are doing. If you are trying to simulate what the human body may pull out of a device once the body is exposed to a device. Then you are trying to assess what the hazards are from that exposure. That’s what we use extraction to do.” –Don Pohl

“Who has ever designed a medical device to be suitable for extraction in various vehicles at temperatures higher that is intended to be use? That is literally what you’re asking yourself when considering part 12. You didn’t design it to test it, you designed it to do what it’s supposed to in a clinical application. This causes some frustration.” –Don Pohl

Key Discussion Points include:

  • What is the importance of working with your laboratory on selecting extraction conditions?
  • Where were the extraction conditions developed?
  • What is the rule of thumb to select the appropriate conditions?
  • How do you consider the steps to not degrade the extracted chemicals?

Also be sure to check out our Biocompatibility Strategy Navigator.

Sheri Krajewski

Sheri Krajewski

Sheri joined NAMSA in 2003 and currently serves as Senior Global Product Marketing Manager of Biological Safety. Sheri has supported customers in a variety of commercial operations and management roles, and was an integral leader in the development of NAMSA’s Biological Safety Consulting business. Additionally, she created the much sought-after NAMSA Training Series (NTS) for the iological evaluation of medical devices. Prior to NAMSA, Sheri was the marketing lead for a mechanical fatigue laboratory and consulting business where she worked primarily with cardiovascular implant manufacturers. Sheri holds a Bachelor’s Degree from the University of Nebraska.

Don Pohl

Don Pohl

Don Pohl is currently the Manager of Biological Safety & Validation at NAMSA. He holds a Bachelor’s degree from Ohio State University. Don has over 20 years of experience in the pre-clinical evaluation of medical devices for biological safety. During his career, he has held a variety of positions ranging from laboratory supervision/management, GLP Study Director, Technical Specialist for Laboratory Information Management System, Technical Specialist and project manager for Biological safety and biological risk assessment consultation. He has specific expertise in the evaluation process outlined in ISO 10993-1 as well as the expectations of the USFDA and other countries in their interpretation of the biological safety evaluation of medical devices.

Let’s Talk About Your Project

Ask a question or request a meeting with a NAMSA expert to discuss your specific project. We will follow up as quickly as possible. Also, please tell us how you heard about NAMSA.

    By choosing to submit your information to contact NAMSA, you are providing NAMSA consent to process and store your information on the NAMSA Network. At any time, you can submit a request to withdraw your consent for the use of information provided by you. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.